Nutrition in Patient With Critical Limb Ischemia
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Medical Center
- Study ID
- NCT03529019
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Critical Limb Ischemia
- Malnutrition
- Nutritional Supplements
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ensure Surgery Immunonutrition Shake — DRUGAn FDA approved nutritional supplement. Prepackaged product designed to be administered one week prior to and one week post surgical procedures.
- Ensure Enlive Advanced Nutrition Shake — DRUGAn FDA approved nutritional supplement. Prepackaged product designed to be administered 2 weeks prior to and 2 weeks post surgical procedure for a period of one week. .
Study Details
A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutritional status, which in turn may improve the patient's clinical status after surgery.
Key Dates
- Start date
- Oct 2, 2018
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Nutritional SupplementAdministration of Ensure Surgery Immunonutrition Shake and ensure Enlive Advanced Nutrition Shake.
Primary Outcome Measure
Change in serum albumin levels [ Time Frame: baseline and 30 days ]
Central Contacts
- Jeffrey J Siracuse, MD617-638-8488
- Myriam Castagne, B.S617-638-8622
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Medical Center | Boston | Massachusetts | 02118 |
Find similar trials in Boston, MA
By research site
Related Studies
- PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening IschemiaRecruiting · LimFlow, Inc. · La Jolla, California
- Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruiting · Fresenius Kabi · Fountain Valley, California
- Trial to Assess Chelation Therapy in Critical Limb IschemiaPHASE3 · Recruiting · Mt. Sinai Medical Center, Miami · Miami Beach, Florida
- RCT: Early Feeding After PEG PlacementRecruiting · Carilion Clinic · Roanoke, Virginia